Hexarelin diminishes within weeks Long-term Use: Ipamorelin preferred for protocols exceeding 2-4 weeks Synergy with GHRH: Both synergize with CJC-1295/Sermorelin Hexarelin Cardiac Research Hexarelin has unique cardiac properties: Cardiac GHS Receptors: Activates GH secretagogue receptors in heart tissue Cardioprotection: Demonstrated protective effects in ischemia/reperfusion models LV Function: Improved left ventricular function in heart failure research Unique Among GHRPs: These cardiac effects are not shared by Ipamorelin Research Application Differences Application-specific preferences: Pure GH Research: Ipamorelin (clean signal, no confounding) Cardiac Research: Hexarelin (unique cardiac effects) Long-term Protocols: Ipamorelin (no desensitization) Acute Maximal GH: Hexarelin (highest peak, short-term only) Safety and Tolerability Profile Hexarelin Safety Profile: Cortisol Elevation: Significant

SCFAs including acetate, propionate, and butyrate are created by gut bacteria during the fermentation of dietary fiber and play an important role in maintaining intestinal health and lowering inflammation
Together, they can help support healthy blood sugar balance, hormone function, and insulin signalling
Most patients do not need to discontinue GLP-1 therapy for modest heart rate increases
What is the main difference between how semaglutide and tirzepatide work
For Canadian patients currently using Semaglutide who have plateaued or want more aggressive weight loss, Retatrutide represents a significant potential upgrade